Faralimomab

From WikiMD.org
Jump to navigation Jump to search

Faralimomab

Faralimomab (pronunciation: fah-rah-lee-moh-mab) is a monoclonal antibody designed for the treatment of various medical conditions.

Etymology

The name "Faralimomab" is derived from the International Nonproprietary Names (INN), where "mab" at the end signifies it as a monoclonal antibody. The prefix "Fara" is arbitrary and does not carry a specific meaning.

Usage

Faralimomab is used in the field of medicine and pharmacology for the treatment of diseases. As a monoclonal antibody, it is designed to target and bind to specific cells or proteins, which stimulates the patient's immune system to attack those cells.

Related Terms

  • Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Pharmacology: The branch of medicine that deals with the uses, effects, and modes of action of drugs.
  • Medicine: The science and practice of diagnosing, treating, or preventing disease and other damage to the body or mind.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski